MDCG Guidance Clarifies IVDR Product Classification and Scope
Despite over a year having passed since publication of Version 3 of the Manual on borderline and…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 136–144 of 229
Despite over a year having passed since publication of Version 3 of the Manual on borderline and…
The MDCG (Medical Device Coordination Group) has released a guidance document titled “Corrective and Preventive Action (CAPA)…
The European Medicines Agency (EMA) has launched a pilot program aimed at supporting manufacturers of high-risk medical…
The IGJ, or the National Competent Authority of the Netherlands, published a report as a call to manufacturers to focus…
A joint statement by Swiss Medtech, SVDI, and MedTech Europe highlights the industry’s support for the ongoing EU-Switzerland negotiations…
On September 25, 2024, the FDA published a proposed change to the classification rules for several…
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an updated guidance for notifying clinical investigations involving medical…
The MDCG 2021-4 rev.1 document, updated in September 2024, offers essential guidance on Class D IVD Certification,…
The European Union has introduced new standards to enhance the safety and quality of substances of human origin (SoHO), such…
Showing 136–144 of 229